DEA Considers Catalent Pharma Solutions for Importer Registration of 4 Controlled Substances
September 13, 2025
September 13, 2025
WASHINGTON, Sept. 13 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration has received an application from Catalent Pharma Solutions LLC, Philadelphia, Pennsylvania, for registration as an importer of specific controlled substances. The company submitted its application on June 11, 2025.
Catalent Pharma Solutions LLC plans to import four different controlled substances, all classified as Schedule I drugs: Ibogaine, Lysergic acid diethylamide, 5-Methoxy-N-N-dimet . . .
Catalent Pharma Solutions LLC plans to import four different controlled substances, all classified as Schedule I drugs: Ibogaine, Lysergic acid diethylamide, 5-Methoxy-N-N-dimet . . .